How is xenon 133 produced

Citation, DOI and article data. Jones, J. Reference article, Radiopaedia. Central Nervous System , Chest. URL of Article. Mode of decay: Beta decay photon energy : 81 KeV physical half-life: 5. Postperfusion xenon ventilation scintigraphy with a narrow window. Related articles: Imaging technology. Promoted articles advertising. Loading more images This image can help to determine how well the lungs are functioning.

The patient will not suffer from the gas, as the xenon will leave the body when exhaling. NRG irradiates targets: aluminum plates including a layer of low enriched uranium.

During irradiation of these plates in the reactor, fission of uranium takes place; a process yielding xenon among other materials. Then, Curium extracts the Xe from the targets using a physical-chemical process. Curium delivers the isotope to hospitals in small vials. The half-life of xenon is approximately 5. Thus, it is a big advantage to have the entire production process located at one site in Petten NL and a quality reduction during transport is avoided.

Thanks to Curium's expertise and distribution network, approximately , patients have been scanned using this technique in , primarily in the United States. Xenon can also be used to measure the cerebral blood flow, however, is rarely used for this purpose as other methods are more suitable. Thanks to intensive collaboration between Curium and NRG, a complex project has been brought to a successful conclusion: the development and installation of a production process for the medical isotope Xenon Producing medical isotopes using only low enriched uranium?

After a challenging design process, Curium and NRG are the first in Europe to produce molybdenum with low enriched uranium. Recognizing the commitments made during the Nuclear Summit , to phase out high enriched uranium HEU based medical isotopes. A complex project has been brought to a successful conclusion: the development and installation of a production process for xenon gas.

Like to receive updates about all the nucleair solutions, innovations in the health industry? The move follows the successful collaboration between nuclear medicine company Curium and the Nuclear Research and Consultancy Group NRG to develop and install a production process for the isotope.

The Xe gas is being produced during the existing Molybdenum production process in Petten, which has recently been fully based on low-enriched uranium LEU targets. This is a good example of how Petten anticipates the demand for different isotopes. Curium in Petten sends the Xe to its sister company in the USA, where the pure bulk is converted to the final product.